Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders??? Equity (Unaudited)

v3.25.4
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance, common (in shares) at Mar. 31, 2024   102,118,932          
Beginning balance at Mar. 31, 2024 $ 213,932 $ 10 $ 100 $ (71) $ 858,191 $ (48,955) $ (595,343)
Beginning balance, preferred (in shares) at Mar. 31, 2024     100,000        
Beginning balance, treasury (in shares) at Mar. 31, 2024       758,125      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (25,156)           (25,156)
Foreign currency translation (1,213)         (1,213)  
Stock-based compensation expense 8,424       8,424    
Shares issued:              
Exercise of stock options (in shares)   8,599          
Exercise of stock options 14       14    
Issuance of restricted shares and vesting of restricted units (in shares)   390,752          
Payment of withholding taxes related to the net share settlement of equity awards (48)       (48)    
Ending balance, common (in shares) at Jun. 30, 2024   102,518,283          
Ending balance at Jun. 30, 2024 195,953 $ 10 $ 100 $ (71) 866,581 (50,168) (620,499)
Ending balance, preferred (in shares) at Jun. 30, 2024     100,000        
Ending balance, treasury (in shares) at Jun. 30, 2024       758,125      
Beginning balance, common (in shares) at Mar. 31, 2024   102,118,932          
Beginning balance at Mar. 31, 2024 213,932 $ 10 $ 100 $ (71) 858,191 (48,955) (595,343)
Beginning balance, preferred (in shares) at Mar. 31, 2024     100,000        
Beginning balance, treasury (in shares) at Mar. 31, 2024       758,125      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (73,273)            
Foreign currency translation (3,175)            
Ending balance, common (in shares) at Dec. 31, 2024   104,834,978          
Ending balance at Dec. 31, 2024 163,563 $ 10 $ 100 $ (71) 884,270 (52,130) (668,616)
Ending balance, preferred (in shares) at Dec. 31, 2024     100,000        
Ending balance, treasury (in shares) at Dec. 31, 2024       758,125      
Beginning balance, common (in shares) at Jun. 30, 2024   102,518,283          
Beginning balance at Jun. 30, 2024 195,953 $ 10 $ 100 $ (71) 866,581 (50,168) (620,499)
Beginning balance, preferred (in shares) at Jun. 30, 2024     100,000        
Beginning balance, treasury (in shares) at Jun. 30, 2024       758,125      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (24,986)           (24,986)
Foreign currency translation 2,157         2,157  
Stock-based compensation expense 9,279       9,279    
Shares issued:              
Exercise of stock options (in shares)   1,667          
Exercise of stock options 79       79    
Issuance of restricted shares and vesting of restricted units (in shares)   1,001,502          
Payment of withholding taxes related to the net share settlement of equity awards (112)       (112)    
Ending balance, common (in shares) at Sep. 30, 2024   103,521,452          
Ending balance at Sep. 30, 2024 182,370 $ 10 $ 100 $ (71) 875,827 (48,011) (645,485)
Ending balance, preferred (in shares) at Sep. 30, 2024     100,000        
Ending balance, treasury (in shares) at Sep. 30, 2024       758,125      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (23,131)           (23,131)
Foreign currency translation (4,119)         (4,119)  
Stock-based compensation expense 8,504       8,504    
Shares issued:              
Exercise of stock options (in shares)   9,537          
Exercise of stock options 10       10    
Issuance of restricted shares and vesting of restricted units (in shares)   1,303,989          
Payment of withholding taxes related to the net share settlement of equity awards (71)       (71)    
Ending balance, common (in shares) at Dec. 31, 2024   104,834,978          
Ending balance at Dec. 31, 2024 $ 163,563 $ 10 $ 100 $ (71) 884,270 (52,130) (668,616)
Ending balance, preferred (in shares) at Dec. 31, 2024     100,000        
Ending balance, treasury (in shares) at Dec. 31, 2024       758,125      
Beginning balance, common (in shares) at Mar. 31, 2025 105,977,642 105,977,642          
Beginning balance at Mar. 31, 2025 $ 153,958 $ 10 $ 100 $ (71) 892,665 (51,304) (687,442)
Beginning balance, preferred (in shares) at Mar. 31, 2025 100,000   100,000        
Beginning balance, treasury (in shares) at Mar. 31, 2025 758,125     758,125      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) $ (14,104)           (14,104)
Foreign currency translation 4,200         4,200  
Stock-based compensation expense 6,824       6,824    
Shares issued:              
Exercise of stock options (in shares)   926,215          
Exercise of stock options 1,560       1,560    
Issuance of restricted shares and vesting of restricted units (in shares)   1,008,970          
Payment of withholding taxes related to the net share settlement of equity awards (144)       (144)    
Ending balance, common (in shares) at Jun. 30, 2025   107,912,827          
Ending balance at Jun. 30, 2025 $ 152,294 $ 10 $ 100 $ (71) 900,905 (47,104) (701,546)
Ending balance, preferred (in shares) at Jun. 30, 2025     100,000        
Ending balance, treasury (in shares) at Jun. 30, 2025       758,125      
Beginning balance, common (in shares) at Mar. 31, 2025 105,977,642 105,977,642          
Beginning balance at Mar. 31, 2025 $ 153,958 $ 10 $ 100 $ (71) 892,665 (51,304) (687,442)
Beginning balance, preferred (in shares) at Mar. 31, 2025 100,000   100,000        
Beginning balance, treasury (in shares) at Mar. 31, 2025 758,125     758,125      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) $ (30,392)            
Foreign currency translation $ (1,264)            
Shares issued:              
Exercise of stock options (in shares) 1,196,522            
Ending balance, common (in shares) at Dec. 31, 2025 119,614,167 119,614,167          
Ending balance at Dec. 31, 2025 $ 194,602 $ 10 $ 100 $ (71) 964,965 (52,568) (717,834)
Ending balance, preferred (in shares) at Dec. 31, 2025 100,000   100,000        
Ending balance, treasury (in shares) at Dec. 31, 2025 758,125     758,125      
Beginning balance, common (in shares) at Jun. 30, 2025   107,912,827          
Beginning balance at Jun. 30, 2025 $ 152,294 $ 10 $ 100 $ (71) 900,905 (47,104) (701,546)
Beginning balance, preferred (in shares) at Jun. 30, 2025     100,000        
Beginning balance, treasury (in shares) at Jun. 30, 2025       758,125      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (21,395)           (21,395)
Foreign currency translation (2,204)         (2,204)  
Stock-based compensation expense 5,930       5,930    
Shares issued:              
Exercise of stock options (in shares)   42,278          
Exercise of stock options 85       85    
Issuance of restricted shares and vesting of restricted units (in shares)   671,509          
Issuance of common stock in connection with at-the-market offering, net of issuance costs (in shares)   3,125,089          
Issuance of common stock in connection with at-the-market offering, net of issuance costs 13,573       13,573    
Payment of withholding taxes related to the net share settlement of equity awards (157)       (157)    
Ending balance, common (in shares) at Sep. 30, 2025   111,751,703          
Ending balance at Sep. 30, 2025 148,126 $ 10 $ 100 $ (71) 920,336 (49,308) (722,941)
Ending balance, preferred (in shares) at Sep. 30, 2025     100,000        
Ending balance, treasury (in shares) at Sep. 30, 2025       758,125      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 5,107           5,107
Foreign currency translation (3,260)         (3,260)  
Stock-based compensation expense 934       934    
Shares issued:              
Exercise of stock options (in shares)   228,029          
Exercise of stock options 662       662    
Issuance of restricted shares and vesting of restricted units (in shares)   814,388          
Issuance of common stock in connection with at-the-market offering, net of issuance costs (in shares)   6,820,047          
Issuance of common stock in connection with at-the-market offering, net of issuance costs 43,236       43,236    
Payment of withholding taxes related to the net share settlement of equity awards $ (203)       (203)    
Ending balance, common (in shares) at Dec. 31, 2025 119,614,167 119,614,167          
Ending balance at Dec. 31, 2025 $ 194,602 $ 10 $ 100 $ (71) $ 964,965 $ (52,568) $ (717,834)
Ending balance, preferred (in shares) at Dec. 31, 2025 100,000   100,000        
Ending balance, treasury (in shares) at Dec. 31, 2025 758,125     758,125